Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 99

1.

Reply to P.H. Sugarbaker.

Nakakura EK.

J Clin Oncol. 2013 Jan 20;31(3):397-8. No abstract available.

PMID:
23451355
[PubMed - indexed for MEDLINE]
Free Article
2.

Pseudomyxoma peritonei: more questions than answers.

Nakakura EK.

J Clin Oncol. 2012 Jul 10;30(20):2429-30. doi: 10.1200/JCO.2012.42.3764. Epub 2012 May 21. No abstract available.

PMID:
22614983
[PubMed - indexed for MEDLINE]
Free Article
3.

Avoiding a throwback to the past.

Sugarbaker PH.

J Clin Oncol. 2013 Jan 20;31(3):396-7. doi: 10.1200/JCO.2012.46.0675. Epub 2012 Dec 26. No abstract available.

PMID:
23269997
[PubMed - indexed for MEDLINE]
Free Article
4.

Early- and long-term outcome data of patients with pseudomyxoma peritonei from appendiceal origin treated by a strategy of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.

Chua TC, Moran BJ, Sugarbaker PH, Levine EA, Glehen O, Gilly FN, Baratti D, Deraco M, Elias D, Sardi A, Liauw W, Yan TD, Barrios P, Gómez Portilla A, de Hingh IH, Ceelen WP, Pelz JO, Piso P, González-Moreno S, Van Der Speeten K, Morris DL.

J Clin Oncol. 2012 Jul 10;30(20):2449-56. doi: 10.1200/JCO.2011.39.7166. Epub 2012 May 21.

PMID:
22614976
[PubMed - indexed for MEDLINE]
Free Article
5.

Clinical results of cytoreduction and HIPEC in pseudomyxoma peritonei.

Lutton NJ, Moran BJ.

Cancer Treat Res. 2007;134:319-28. Review. No abstract available.

PMID:
17633063
[PubMed - indexed for MEDLINE]
6.

New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome?

Sugarbaker PH.

Lancet Oncol. 2006 Jan;7(1):69-76. Review.

PMID:
16389186
[PubMed - indexed for MEDLINE]
7.

Intraoperative hyperthermic intrathoracic chemotherapy for pleural extension of pseudomyxoma peritonei.

Dang A, Mansfield P, Ilsin B, Hightower C, Aravindan N, Rice D, Riedel B.

J Cardiothorac Vasc Anesth. 2007 Apr;21(2):265-8. Epub 2006 Aug 23. No abstract available.

PMID:
17418746
[PubMed - indexed for MEDLINE]
8.

Evolution of locoregional treatment for peritoneal carcinomatosis: single-center experience of 308 procedures of cytoreductive surgery and perioperative intraperitoneal chemotherapy.

Chua TC, Liauw W, Saxena A, Al-Mohaimeed K, Fransi S, Zhao J, Morris DL.

Am J Surg. 2011 Feb;201(2):149-56. doi: 10.1016/j.amjsurg.2010.02.012. Epub 2010 Sep 15.

PMID:
20832051
[PubMed - indexed for MEDLINE]
9.

[Cytoreductive surgery (peritonectomy) and intraperitoneal hyperthermic chemotherapy: an innovative and effective approach to the treatment of pseudomyxoma peritonei].

Deraco M, Kusamura S, Gronchi A.

Tumori. 2003 Jul-Aug;89(4 Suppl):54-5. Italian.

PMID:
12903545
[PubMed - indexed for MEDLINE]
10.

[Clinical practice guideline on peritoneal carcinomatosis treatment using surgical cytoreduction and hyperthermic intraoperative intraperitoneal chemotherapy].

Kavanagh M, Ouellet JF; Comité de l'Evolution des Pratiques en Oncologie.

Bull Cancer. 2006 Sep;93(9):867-74. Review. French.

PMID:
16980229
[PubMed - indexed for MEDLINE]
11.

The current role of hyperthermic intraperitoneal chemotherapy for peritoneal dissemination of appendiceal tumors.

Stewart JH 4th, Levine EA, Shen P.

Curr Probl Cancer. 2009 May-Jun;33(3):142-53. doi: 10.1016/j.currproblcancer.2009.06.002. Review. No abstract available.

PMID:
19647613
[PubMed - indexed for MEDLINE]
12.

Treatment of pseudomyxoma peritonei in a geriatric patient population.

Sullivan MH, Sugarbaker PH.

J Surg Oncol. 1995 Feb;58(2):121-4.

PMID:
7844982
[PubMed - indexed for MEDLINE]
13.

Commentary on 'Survival of patients with pseudomyxoma peritonei treated by serial debulking'.

Moran BJ.

Colorectal Dis. 2010 Sep;12(9):872-3. doi: 10.1111/j.1463-1318.2010.02340.x. No abstract available.

PMID:
20718839
[PubMed - indexed for MEDLINE]
14.

Patterns of failure following treatment of pseudomyxoma peritonei of appendiceal origin.

Zoetmulder FA, Sugarbaker PH.

Eur J Cancer. 1996 Sep;32A(10):1727-33.

PMID:
8983281
[PubMed - indexed for MEDLINE]
15.

An instrument to provide containment of intraoperative intraperitoneal chemotherapy with optimized distribution.

Sugarbaker PH.

J Surg Oncol. 2005 Nov 1;92(2):142-6. No abstract available.

PMID:
16231365
[PubMed - indexed for MEDLINE]
16.

An evidence-based approach: Sugarbaker protocol and pseudomyxoma peritonei of appendiceal origin.

Lo CH, Bohmer RD, Blomfield PI.

ANZ J Surg. 2008 May;78(5):327-8. doi: 10.1111/j.1445-2197.2008.04462.x. No abstract available.

PMID:
18380718
[PubMed - indexed for MEDLINE]
17.

Re: An evidence-based approach: Sugarbaker protocol and pseudomyxoma peritonei of appendiceal origin.

Morris DL.

ANZ J Surg. 2008 Nov;78(11):1043; author reply 1043. doi: 10.1111/j.1445-2197.2008.04733.x. No abstract available.

PMID:
18959716
[PubMed - indexed for MEDLINE]
18.

Determining the association between preoperative computed tomography findings and postoperative outcomes after cytoreductive surgery and perioperative intraperitoneal chemotherapy for pseudomyxoma peritonei.

Chua TC, Al-Zahrani A, Saxena A, Glenn D, Liauw W, Zhao J, Morris DL.

Ann Surg Oncol. 2011 Jun;18(6):1582-9. doi: 10.1245/s10434-010-1492-3. Epub 2011 Jan 5.

PMID:
21207170
[PubMed - indexed for MEDLINE]
19.

Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei.

Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FA.

Br J Surg. 2001 Mar;88(3):458-63.

PMID:
11260116
[PubMed - indexed for MEDLINE]
20.

Therapy of pseudomyxoma peritonei of appendiceal origin--surgical resection and intraperitoneal chemotherapy.

Hosch WP, Rudi J, Stremmel W.

Z Gastroenterol. 1999 Jul;37(7):615-22.

PMID:
10458011
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk